Mark Sieczkarek
2015
In 2015, Mark Sieczkarek earned a total compensation of $102.3K as Chairman of the Board and CEO at NovaBay Pharmaceuticals.
Compensation breakdown
| Option Awards | $78,532 |
|---|---|
| Other | $23,750 |
| Total | $102,282 |
Sieczkarek received $78.5K in option awards, accounting for 77% of the total pay in 2015.
Sieczkarek also received $23.8K in other compensation.
Rankings
In 2015, Mark Sieczkarek's compensation ranked 13,448th out of 13,638 executives tracked by ExecPay. In other words, Sieczkarek earned more than 1.4% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 13,448 out of 13,638 | 1st |
Division Manufacturing | 5,137 out of 5,190 | 1st |
Major group Chemicals And Allied Products | 1,835 out of 1,854 | 1st |
Industry group Drugs | 1,512 out of 1,528 | 1st |
Industry Pharmaceutical Preparations | 1,171 out of 1,182 | 1st |
Source: SEC filing on April 21, 2017.
Sieczkarek's colleagues
We found two more compensation records of executives who worked with Mark Sieczkarek at NovaBay Pharmaceuticals in 2015.